抗菌素抗药性监测市场规模、份额和成长分析（按组件、技术、最终用户和地区）- 产业预测（2025-2032）

预计 2023 年全球抗生素抗药性监测市场价值将达到 59 亿美元，并从 2024 年的 62.3 亿美元成长到 2032 年的 96.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.6%。

抗生素抗药性的蔓延已成为全球面临的重大健康挑战，促使各国政府、卫生组织和国际机构日益关注健全的监测系统。抗药性感染疾病的增加导致对快速资料收集、病原体追踪和抗药性模式评估的需求激增，凸显了对先进的抗生素抗药性监测能力的需求，这些能力有助于快速检测并做出明智的临床决策。人们对公共卫生防范和感染控制的日益关注正推动市场扩张。同时，监管倡议和全球行动框架正在推动监测能力的提升。各国正在投资实验室基础设施和整合数据系统，以实现即时报告，从而提高调查效率。医疗保健提供者正在利用这些系统加强感染控制，并强调抗生素管理，以减少医院相关感染，最终支持市场加速成长。

目录

介绍

• 分析目的
• 市场覆盖
• 定义

分析方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况与展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考量因素

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场魅力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究

全球抗菌素抗药性监测市场规模及各组成部分的复合年增长率（2025-2032）

• 市场概览
• 软体
• 硬体
• 服务

全球抗菌素抗药性监测市场规模及复合年增长率（按技术划分）（2025-2032 年）

• 市场概览
• 表型方法
• 基因分型方法
• 生物资讯解决方案

全球抗菌素抗药性监测市场规模及最终用户复合年增长率（2025-2032）

• 市场概览
• 医院和诊所
• 诊断实验室
• 製药和生物技术公司
• 学术研究机构
• 公共卫生机构

全球抗菌素抗药性监测市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业的市场定位（2024年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益同比对比（2022-2024 年）

主要企业简介

• 生物梅里埃公司（法国）
• 赛默飞世尔科技公司（美国）
• BD（美国）
• 罗氏诊断（瑞士）
• OpGen公司（美国）
• Luminex公司（美国）
• Accelerate Diagnostics Inc.（美国）
• 默克集团（德国）
• 丹纳赫公司（美国）
• 布鲁克公司（美国）
• QuantuMDx集团有限公司（英国）
• ArcBio LLC（美国）
• Bugworks Research Inc.（印度）

结论和建议

Global Antimicrobial Resistance Surveillance Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.23 billion in 2024 to USD 9.63 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The escalating prevalence of antimicrobial resistance poses significant global health challenges, prompting heightened attention from governments, health organizations, and international bodies toward robust surveillance systems. The necessity for swift data collection, pathogen tracking, and resistance pattern assessment is surging in response to increasing drug-resistant infections, emphasizing the demand for advanced antimicrobial resistance surveillance capabilities that facilitate quick detection and informed clinical choices. This intensified focus on public health readiness and infection management is catalyzing market expansion. Concurrently, regulatory initiatives and global action frameworks are pressuring enhancements in surveillance capabilities. Nations are investing in laboratory infrastructure and integrated data systems for real-time reporting, thereby bolstering surveying efficiency. Healthcare providers leverage these systems to enhance infection control, emphasizing antimicrobial stewardship and reducing healthcare-associated infections, ultimately supporting accelerated market development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Surveillance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Surveillance Market Segments Analysis

Global Antimicrobial Resistance Surveillance Market is segmented by Component, Technology, End User and region. Based on Component, the market is segmented into Software, Hardware and Services. Based on Technology, the market is segmented into Phenotypic Methods, Genotypic Methods and Bioinformatics Solutions. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Public Health Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Surveillance Market

The growing prevalence of drug-resistant infections is now a significant public health concern, prompting urgent attention from health authorities worldwide. As resistance rates escalate, there is a pressing need for advanced surveillance systems that can monitor resistance patterns in real time, enabling timely interventions. Both national and local governments recognize the critical importance of enhancing antimicrobial resistance surveillance to effectively manage outbreaks, mitigate treatment failures, and inform public health policies. This collective effort to address the escalating issue of antimicrobial resistance has notably driven the expansion of the global antimicrobial resistance surveillance market, reflecting a commitment to safeguarding public health.

Restraints in the Global Antimicrobial Resistance Surveillance Market

The development of an effective antimicrobial resistance surveillance system faces considerable challenges, primarily due to the substantial financial investment needed for laboratory infrastructure, data integration technologies, and skilled workforce training. These constraints are especially pronounced in lower-income nations, where resources are often limited. Furthermore, the considerable expenses involved in analyzing surveillance data through genomic methods hinder the market's expansion and accessibility on a global scale. This combination of financial and operational hurdles poses significant obstacles that can impede the establishment and functionality of comprehensive surveillance systems crucial for combating antimicrobial resistance worldwide.

Market Trends of the Global Antimicrobial Resistance Surveillance Market

The global antimicrobial resistance surveillance market is witnessing a notable trend characterized by the integration of artificial intelligence with genomic surveillance techniques. This fusion enhances the effectiveness of monitoring efforts by utilizing AI-based platforms in conjunction with whole-genome sequencing and advanced bioinformatics tools. Such innovation enables the precise identification of resistance genes, timely outbreak alerts, and refined predictive modeling. Consequently, healthcare systems are empowered to bolster their surveillance capabilities, thereby improving response strategies and mitigating the spread of antimicrobial resistance. This shift towards technological advancements signifies a proactive approach to tackling one of the most pressing challenges in global health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Antimicrobial Resistance Surveillance Market Size by Component & CAGR (2025-2032)

• Market Overview
• Software
• Hardware
• Services

Global Antimicrobial Resistance Surveillance Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods
• Bioinformatics Solutions

Global Antimicrobial Resistance Surveillance Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Public Health Agencies

Global Antimicrobial Resistance Surveillance Market Size & CAGR (2025-2032)

• North America (Component, Technology, End User)
  • US
  • Canada
• Europe (Component, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcBio LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bugworks Research Inc. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations